Logo

Oncology Drugs Market Size, Share, Growth, and Regional Forecast, 2025 to 2032

Oncology Drugs Market by Drug Class (Chemotherapy, Targeted Therapy, Immunotherapy, and Hormonal Therapy), Indication (Breast Cancer, Lung Cancer, Prostate Cancer, Multiple Myeloma, Colorectal Cancer, Non-Hodgkin's Lymphoma, Kidney Cancer, Chronic lymphocytic Leukaemia, Melanoma, and Others), Route of Administration, Distribution Channel, and Regional Analysis from 2025 to 2032

ID: PMRREP3312
Calendar

December 2025

406 Pages

Author : Abhijeet Surwase

Healthcare
  1. Executive Summary
    1. Global Oncology Drugs Market Snapshot, 2025 and 2032
    2. Market Opportunity Assessment, 2025 - 2032, US$ Bn
    3. Key Market Trends
    4. Future Market Projections
    5. Premium Market Insights
    6. Industry Developments and Key Market Events
    7. PMR Analysis and Recommendations
  2. Market Overview
    1. Market Scope and Definition
    2. Market Dynamics
      1. Drivers
      2. Restraints
      3. Opportunity
      4. Challenges
      5. Key Trends
    3. COVID-19 Impact Analysis
    4. Forecast Factors - Relevance and Impact
  3. Value Added Insights
    1. Value Chain Analysis
    2. Diseases Epidemiology
    3. Pipeline Assessment
    4. Reimbursement Outlook
    5. Product Adoption / Usage Analysis
    6. Key Market Players
    7. Key Promotional Strategies, By Key Players
    8. Regulatory Landscape
    9. PESTLE Analysis
    10. Porter’s Five Force Analysis
  4. Global Oncology Drugs Market Outlook
    1. Key Highlights
      1. Market Size (US$ Bn) and Y-o-Y Growth
      2. Absolute $ Opportunity
    2. Market Size (US$ Bn) Analysis and Forecast
      1. Historical Market Size (US$ Bn) Analysis, 2019-2024
      2. Market Size (US$ Bn) Analysis and Forecast, 2025-2032
    3. Global Oncology Drugs Market Outlook: Drug Class
      1. Historical Market Size (US$ Bn) Analysis, By Drug Class, 2019-2024
      2. Market Size (US$ Bn) Analysis and Forecast, By Drug Class, 2025-2032
        1. Chemotherapy
          1. Alkylating Agents
          2. Antimetabolites
          3. Anti-tumour Antibiotics
          4. Topoisomerase Inhibitors
          5. Mitotic Inhibitors
          6. Others
        2. Targeted Therapy
          1. Monoclonal Antibodies
          2. Small molecule Inhibitors
        3. Immunotherapy
          1. Immune Checkpoint Inhibitors
          2. Cell Therapy and Gene Therapy
          3. Oncolytic Virus Therapy
          4. Immune System Modulators
          5. Others
        4. Hormonal Therapy
      3. Market Attractiveness Analysis: Drug Class
    4. Global Oncology Drugs Market Outlook: Indication
      1. Historical Market Size (US$ Bn) Analysis, By Indication, 2019-2024
      2. Market Size (US$ Bn) Analysis and Forecast, By Indication, 2025-2032
        1. Breast Cancer
        2. Lung Cancer
        3. Prostate Cancer
        4. Multiple Myeloma
        5. Colorectal Cancer
        6. Non-Hodgkin's Lymphoma
        7. Kidney Cancer
        8. Chronic lymphocytic Leukaemia
        9. Melanoma
        10. Others
      3. Market Attractiveness Analysis: Indication
    5. Global Oncology Drugs Market Outlook: Route of Administration
      1. Historical Market Size (US$ Bn) Analysis, By Route of Administration, 2019-2024
      2. Market Size (US$ Bn) Analysis and Forecast, By Route of Administration, 2025-2032
        1. Oral
        2. Injectable
      3. Market Attractiveness Analysis: Route of Administration
    6. Global Oncology Drugs Market Outlook: Distribution Channel
      1. Historical Market Size (US$ Bn) Analysis, By Distribution Channel, 2019-2024
      2. Market Size (US$ Bn) Analysis and Forecast, By Distribution Channel, 2025-2032
        1. Hospital Pharmacies
        2. Retail Pharmacies
        3. Others
      3. Market Attractiveness Analysis: Distribution Channel
  5. Global Oncology Drugs Market Outlook: Region
    1. Historical Market Size (US$ Bn) Analysis, By Region, 2019-2024
    2. Market Size (US$ Bn) Analysis and Forecast, By Region, 2025-2032
      1. North America
      2. Latin America
      3. Europe
      4. East Asia
      5. South Asia and Oceania
      6. Middle East & Africa
    3. Market Attractiveness Analysis: Region
  6. North America Oncology Drugs Market Outlook
    1. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
      1. By Country
      2. By Drug Class
      3. By Indication
      4. By Route of Administration
      5. By Distribution Channel
    2. Market Size (US$ Bn) Analysis and Forecast by Country, 2025-2032
      1. U.S.
      2. Canada
    3. Market Size (US$ Bn) Analysis and Forecast, By Drug Class, 2025-2032
      1. Chemotherapy
        1. Alkylating Agents
        2. Antimetabolites
        3. Anti-tumour Antibiotics
        4. Topoisomerase Inhibitors
        5. Mitotic Inhibitors
        6. Others
      2. Targeted Therapy
        1. Monoclonal Antibodies
        2. Small molecule Inhibitors
      3. Immunotherapy
        1. Immune Checkpoint Inhibitors.
        2. Cell Therapy and Gene Therapy
        3. Oncolytic Virus Therapy
        4. Immune System Modulators
        5. Others
      4. Hormonal Therapy
    4. Market Size (US$ Bn) Analysis and Forecast, By Indication, 2025-2032
      1. Breast Cancer
      2. Lung Cancer
      3. Prostate Cancer
      4. Multiple Myeloma
      5. Colorectal Cancer
      6. Non-Hodgkin's Lymphoma
      7. Kidney Cancer
      8. Chronic lymphocytic Leukaemia
      9. Melanoma
      10. Others
    5. Market Size (US$ Bn) Analysis and Forecast, By Route of Administration, 2025-2032
      1. Oral
      2. Injectable
    6. Market Size (US$ Bn) Analysis and Forecast, By Distribution Channel, 2025-2032
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Others
    7. Market Attractiveness Analysis
  7. Europe Oncology Drugs Market Outlook
    1. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
      1. By Country
      2. By Drug Class
      3. By Indication
      4. By Route of Administration
      5. By Distribution Channel
    2. Market Size (US$ Bn) Analysis and Forecast by Country, 2025-2032
      1. Germany
      2. France
      3. U.K.
      4. Italy
      5. Spain
      6. Russia
      7. Rest of Europe
    3. Market Size (US$ Bn) Analysis and Forecast, By Drug Class, 2025-2032
      1. Chemotherapy
        1. Alkylating Agents
        2. Antimetabolites
        3. Anti-tumour Antibiotics
        4. Topoisomerase Inhibitors
        5. Mitotic Inhibitors
        6. Others
      2. Targeted Therapy
        1. Monoclonal Antibodies
        2. Small molecule Inhibitors
      3. Immunotherapy
        1. Immune Checkpoint Inhibitors.
        2. Cell Therapy and Gene Therapy
        3. Oncolytic Virus Therapy
        4. Immune System Modulators
        5. Others
      4. Hormonal Therapy
    4. Market Size (US$ Bn) Analysis and Forecast, By Indication, 2025-2032
      1. Breast Cancer
      2. Lung Cancer
      3. Prostate Cancer
      4. Multiple Myeloma
      5. Colorectal Cancer
      6. Non-Hodgkin's Lymphoma
      7. Kidney Cancer
      8. Chronic lymphocytic Leukaemia
      9. Melanoma
      10. Others
    5. Market Size (US$ Bn) Analysis and Forecast, By Route of Administration, 2025-2032
      1. Oral
      2. Injectable
    6. Market Size (US$ Bn) Analysis and Forecast, By Distribution Channel, 2025-2032
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Others
    7. Market Attractiveness Analysis
  8. East Asia Oncology Drugs Market Outlook
    1. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
      1. By Country
      2. By Drug Class
      3. By Indication
      4. By Route of Administration
      5. By Distribution Channel
    2. Market Size (US$ Bn) Analysis and Forecast by Country, 2025-2032
      1. China
      2. Japan
      3. South Korea
    3. Market Size (US$ Bn) Analysis and Forecast, By Drug Class, 2025-2032
      1. Chemotherapy
        1. Alkylating Agents
        2. Antimetabolites
        3. Anti-tumour Antibiotics
        4. Topoisomerase Inhibitors
        5. Mitotic Inhibitors
        6. Others
      2. Targeted Therapy
        1. Monoclonal Antibodies
        2. Small molecule Inhibitors
      3. Immunotherapy
        1. Immune Checkpoint Inhibitors.
        2. Cell Therapy and Gene Therapy
        3. Oncolytic Virus Therapy
        4. Immune System Modulators
        5. Others
      4. Hormonal Therapy
    4. Market Size (US$ Bn) Analysis and Forecast, By Indication, 2025-2032
      1. Breast Cancer
      2. Lung Cancer
      3. Prostate Cancer
      4. Multiple Myeloma
      5. Colorectal Cancer
      6. Non-Hodgkin's Lymphoma
      7. Kidney Cancer
      8. Chronic lymphocytic Leukaemia
      9. Melanoma
      10. Others
    5. Market Size (US$ Bn) Analysis and Forecast, By Route of Administration, 2025-2032
      1. Oral
      2. Injectable
    6. Market Size (US$ Bn) Analysis and Forecast, By Distribution Channel, 2025-2032
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Others
    7. Market Attractiveness Analysis
  9. South Asia & Oceania Oncology Drugs Market Outlook
    1. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
      1. By Country
      2. By Drug Class
      3. By Indication
      4. By Route of Administration
      5. By Distribution Channel
    2. Market Size (US$ Bn) Analysis and Forecast by Country, 2025-2032
      1. India
      2. Indonesia
      3. Thailand
      4. Singapore
      5. ANZ
      6. Rest of South Asia & Oceania
    3. Market Size (US$ Bn) Analysis and Forecast, By Drug Class, 2025-2032
      1. Chemotherapy
        1. Alkylating Agents
        2. Antimetabolites
        3. Anti-tumour Antibiotics
        4. Topoisomerase Inhibitors
        5. Mitotic Inhibitors
        6. Others
      2. Targeted Therapy
        1. Monoclonal Antibodies
        2. Small molecule Inhibitors
      3. Immunotherapy
        1. Immune Checkpoint Inhibitors.
        2. Cell Therapy and Gene Therapy
        3. Oncolytic Virus Therapy
        4. Immune System Modulators
        5. Others
      4. Hormonal Therapy
    4. Market Size (US$ Bn) Analysis and Forecast, By Indication, 2025-2032
      1. Breast Cancer
      2. Lung Cancer
      3. Prostate Cancer
      4. Multiple Myeloma
      5. Colorectal Cancer
      6. Non-Hodgkin's Lymphoma
      7. Kidney Cancer
      8. Chronic lymphocytic Leukaemia
      9. Melanoma
      10. Others
    5. Market Size (US$ Bn) Analysis and Forecast, By Route of Administration, 2025-2032
      1. Oral
      2. Injectable
    6. Market Size (US$ Bn) Analysis and Forecast, By Distribution Channel, 2025-2032
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Others
    7. Market Attractiveness Analysis
  10. Latin America Oncology Drugs Market Outlook
    1. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
      1. By Country
      2. By Drug Class
      3. By Indication
      4. By Route of Administration
      5. By Distribution Channel
    2. Market Size (US$ Bn) Analysis and Forecast by Country, 2025-2032
      1. Brazil
      2. Mexico
      3. Rest of Latin America
    3. Market Size (US$ Bn) Analysis and Forecast, By Drug Class, 2025-2032
      1. Chemotherapy
        1. Alkylating Agents
        2. Antimetabolites
        3. Anti-tumour Antibiotics
        4. Topoisomerase Inhibitors
        5. Mitotic Inhibitors
        6. Others
      2. Targeted Therapy
        1. Monoclonal Antibodies
        2. Small molecule Inhibitors
      3. Immunotherapy
        1. Immune Checkpoint Inhibitors.
        2. Cell Therapy and Gene Therapy
        3. Oncolytic Virus Therapy
        4. Immune System Modulators
        5. Others
      4. Hormonal Therapy
    4. Market Size (US$ Bn) Analysis and Forecast, By Indication, 2025-2032
      1. Breast Cancer
      2. Lung Cancer
      3. Prostate Cancer
      4. Multiple Myeloma
      5. Colorectal Cancer
      6. Non-Hodgkin's Lymphoma
      7. Kidney Cancer
      8. Chronic lymphocytic Leukaemia
      9. Melanoma
      10. Others
    5. Market Size (US$ Bn) Analysis and Forecast, By Route of Administration, 2025-2032
      1. Oral
      2. Injectable
    6. Market Size (US$ Bn) Analysis and Forecast, By Distribution Channel, 2025-2032
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Others
    7. Market Attractiveness Analysis
  11. Middle East & Africa Oncology Drugs Market Outlook
    1. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
      1. By Country
      2. By Drug Class
      3. By Indication
      4. By Route of Administration
      5. By Distribution Channel
    2. Market Size (US$ Bn) Analysis and Forecast by Country, 2025-2032
      1. GCC Countries
      2. Egypt
      3. South Africa
      4. Northern Africa
      5. Rest of Middle East & Africa
    3. Market Size (US$ Bn) Analysis and Forecast, By Drug Class, 2025-2032
      1. Chemotherapy
        1. Alkylating Agents
        2. Antimetabolites
        3. Anti-tumour Antibiotics
        4. Topoisomerase Inhibitors
        5. Mitotic Inhibitors
        6. Others
      2. Targeted Therapy
        1. Monoclonal Antibodies
        2. Small molecule Inhibitors
      3. Immunotherapy
        1. Immune Checkpoint Inhibitors.
        2. Cell Therapy and Gene Therapy
        3. Oncolytic Virus Therapy
        4. Immune System Modulators
        5. Others
      4. Hormonal Therapy
    4. Market Size (US$ Bn) Analysis and Forecast, By Indication, 2025-2032
      1. Breast Cancer
      2. Lung Cancer
      3. Prostate Cancer
      4. Multiple Myeloma
      5. Colorectal Cancer
      6. Non-Hodgkin's Lymphoma
      7. Kidney Cancer
      8. Chronic lymphocytic Leukaemia
      9. Melanoma
      10. Others
    5. Market Size (US$ Bn) Analysis and Forecast, By Route of Administration, 2025-2032
      1. Oral
      2. Injectable
    6. Market Size (US$ Bn) Analysis and Forecast, By Distribution Channel, 2025-2032
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Others
    7. Market Attractiveness Analysis
  12. Competition Landscape
    1. Market Share Analysis, 2024
    2. Market Structure
      1. Competition Intensity Mapping by Market
      2. Competition Dashboard
    3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
      1. GlaxoSmithKline
        1. Overview
        2. Segments and Distribution Channels
        3. Key Financials
        4. Market Developments
        5. Market Strategy
      2. AstraZeneca plc
      3. AbbVie
      4. Pfizer Inc.
      5. Amgen Inc.
      6. Gilead Sciences, Inc.
      7. F. Hoffmann-La Roche Ltd
      8. Bristol-Myers Squibb Company (Celgene Corp)
      9. Novartis AG
      10. Johnson & Johnson
      11. Merck & Co.
      12. Eli Lilly and Company
      13. Sanofi S.A
      14. Bayer AG
      15. Others
  13. Appendix
    1. Research Methodology
    2. Research Assumptions
    3. Acronyms and Abbreviations
Emailsales@persistencemarketresearch.com
UK

Corporate Office

Persistence Research & Consultancy Services Limited

Company Number : 15310893

Second Floor, 150 Fleet Street,London, EC4A 2DQ.

+44 203-837-5656
USA

Regional Office

Persistence Market Research

108 W 39th Street, Ste 1006,PMB2219, New York, NY 10018

+1 646-878-6329
India

Global Research centre

Persistence Market Research Private Limited

CIN : U74900PN2014PTC153163

IT Unit No. 504, 5th Floor, IconTower, Baner, Pune - 411045.

+91 906 779 3500SIN : +65 6531 3894 98
Quick Links
CareersTerms & ConditionsReturn PolicyMarket Research Report
Customer FAQ’sPrivacy PolicySitemap

Copyright © 2026 Persistence Market Research. All Rights Reserved

Connect With Us -